Doximity, Inc. (DOCS)
41.36
-2.50
(-5.70%)
USD |
NYSE |
Jan 13, 16:00
41.25
-0.11
(-0.27%)
Pre-Market: 09:05
Doximity Research and Development Expense (Quarterly): 30.20M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Certara, Inc. | 10.27M |
| American Well Corp. | 18.58M |
| Spok Holdings, Inc. | 2.993M |
| DarioHealth Corp. | 3.328M |
| National Research Corp. | -- |